Cite
HARVARD Citation
Alexander, B. et al. (n.d.). 1248. Efficacy and Safety of Oral Ibrexafungerp in 41 Patients with Refractory Fungal Diseases, Interim Analysis of a Phase 3 Open-label Study (FURI). Open forum infectious diseases. p. S642. [Online].